The news
David Sacks has stated that OpenAI and Anthropic can slow their AI development voluntarily. He rejects the idea that any such slowdown requires suspension of antitrust laws or the creation of third-party evaluation boards. The position frames the two companies as seeking regulatory relief that existing competition rules do not provide.
Context
Calls for caution among frontier AI developers have sometimes included proposals that tie reduced development speed to changes in law or new oversight structures. Sacks addresses this directly by separating the decision to proceed more deliberately from any demand for legal carve-outs. The prior state assumed that coordinated restraint would need external accommodations before it could occur. Sacks treats the issue as one already covered by current statutes.
Details
The argument rests on two conditions that Sacks identifies as unnecessary. The first is suspension of antitrust laws. The second is establishment of third-party evaluation boards. He states that neither is required for the labs to choose a slower pace on their own. The claim functions as a rebuttal to any suggestion that regulatory changes must come first.
No technical benchmarks, release timelines, or internal development metrics appear in the statement. The focus stays on the institutional prerequisites the labs have reportedly attached to voluntary restraint. Sacks presents the choice to moderate progress as an internal matter that does not alter the legal obligations that apply to other firms.
Why it matters
Sacks’s position removes the premise that safety concerns automatically justify changes to competition policy. If the leading labs can adjust their pace without those changes, the case for exemptions weakens. Companies that have already secured substantial funding and market position would then operate under the same rules as any other firm when deciding how fast to move.
This keeps the discussion inside ordinary antitrust boundaries instead of creating new governance layers specific to AI. The practical effect is to shift the burden back onto internal decisions rather than external legal accommodations. Firms that argue for special treatment must now explain why existing rules block a measured approach, rather than assuming that caution itself requires new statutes.
The stance also narrows the range of policy options available to labs that want both slower progress and protection from competitive pressure. Without antitrust suspension, any coordinated slowdown remains subject to the same scrutiny that applies to other industries. Third-party boards, if created, would then stand on their own merits rather than serving as a condition for legal relief.
For developers and founders outside the two labs, the argument reinforces that market position does not automatically confer the right to rewrite enforcement standards. It treats AI development speed as a business choice that does not require rewriting the rules that govern competition. That framing limits the ability of well-funded players to convert safety rhetoric into regulatory advantage.
The result is a narrower path for any future request that links restraint to exemptions. Regulators and competitors can now point to the claim that voluntary moderation needs no special status. This keeps oversight questions focused on conduct under current law rather than on the creation of new institutions tied to reduced output.
---
Sources:
{"word_count": 612, "sources_used": ["Neowin"]}
No comments yet